NervGen Pharma Corp (NGEN) PT Lowered to $15 at H.C. Wainwright Jul 14, 2026 06:55AM
TD Cowen Starts NervGen Pharma Corp (NGEN) at Buy, 'A New Generation In Spinal Cord Injury Treatment Is Here' Jun 11, 2026 05:32AM
NervGen Pharma Corp. (NGEN) Tops Q1 EPS by 6c May 18, 2026 04:43PM
H.C. Wainwright Reiterates Buy Rating on NervGen Pharma Corp (NGEN) Apr 28, 2026 06:46AM
H.C. Wainwright Starts NervGen Pharma Corp (NGEN) at Buy Apr 27, 2026 06:08AM


Apr 15, 2026 06:05AM Lucid Capital Markets Starts NervGen Pharma Corp (NGEN) at Buy
Apr 8, 2026 03:14PM NervGen Pharma Corp (NGEN) PT Raised to $12 at Maxim Group
Mar 4, 2026 07:31AM NervGen hires Shamim Ruff as regulatory chief, Christine McSherry as SVP